Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Conclusion
The results of this SLR, together with one SLR on safety of DMARD and one on glucocorticoids, informed the taskforce of the 2022 update of the EULAR recommendations for pharmacological management of RA.

Source: Annals of the Rheumatic Diseases - January 3, 2023 Category: Rheumatology Authors: Kerschbaumer, A., Sepriano, A., Bergstra, S. A., Smolen, J. S., van der Heijde, D., Caporali, R., Edwards, C. J., Verschueren, P., de Souza, S., Pope, J. E., Takeuchi, T., Hyrich, K. L., Winthrop, K. L., Aletaha, D., Stamm, T. A., Schoones, J. W., Landewe Tags: ARD, Rheumatoid arthritis Source Type: research